JosephMFlynnDO
Oncology • Louisville, KYAssociate Professor, Internal Medicine, Ohio State University College of Medicine
Dr. Flynn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
676 S Floyd St
Ste 200
Louisville, KY 40202Phone+1 502-629-4440Fax+1 502-629-4445
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1999 - 2002- National Capital ConsortiumResidency, Internal Medicine, 1996 - 1999
Philadelphia College of Osteopathic MedicineClass of 1996
Certifications & Licensure
KY State License 2020 - 2025
OH State License 2007 - 2025
DC State License 1998 - 2008- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia Start of enrollment: 2010 Aug 01
- A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma Start of enrollment: 2011 Oct 13
- Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma Start of enrollment: 2012 Feb 09
- Join now to see all
Publications & Presentations
PubMed
- 96 citationsCD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibodyFarrukh T. Awan, Rosa Lapalombella, Rossana Trotta, Jonathan P. Butchar, Bo Yu
Blood. 2010-02-11 - 612 citationsBruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.Sarah E. M. Herman, Amber Gordon, Erin Hertlein, Asha Ramanunni, Xiaoli Zhang
Blood. 2011-06-09 - 107 citationsA phase 1/1b study of rituximab, bendamustine, and ibrutinib in patients with untreated and relapsed/refractory non-Hodgkin lymphomaKami J. Maddocks, Beth A. Christian, Samantha Jaglowski, Joseph M. Flynn, Jeffery A. Jones
Blood. 2015-01-08
Press Mentions
Kentucky Poison Control Sees Sharp Jump in Calls About People Taking Ivermectin for COVIDSeptember 1st, 2021- Lambda Variant Appears to Be Less Aggressive Than DeltaJuly 27th, 2021
- Louisville Area Health Officials Concerned over Possible Fourth Surge of COVID-19April 9th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
